Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (5,325)	$ (4,897)	$ (2,709)	$ (14,399)
Available for sale securities - net unrealized (loss) income	(14)	2	(14)	34
Total other comprehensive (loss) income	(14)	2	(14)	34
Comprehensive loss	(5,339)	(4,895)	(2,723)	(14,365)
Comprehensive income attributable to noncontrolling interests	2	1	10	6
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders	$ (5,341)	$ (4,896)	$ (2,733)	$ (14,371)